These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. WHO global tuberculosis control report 2010. Summary. Cent Eur J Public Health; 2010 Dec; 18(4):237. PubMed ID: 21361110 [No Abstract] [Full Text] [Related]
3. World Health Organization fact sheet. Tuberculosis. World Health Organization Saudi Med J; 2004 Aug; 25(8):1136-8. PubMed ID: 15457607 [No Abstract] [Full Text] [Related]
4. Southern Africa is moving swiftly to combat the threat of XDR-TB. Wise J Bull World Health Organ; 2006 Dec; 84(12):924-5. PubMed ID: 17242824 [No Abstract] [Full Text] [Related]
6. The International Tuberculosis Surveillance Research Unit (TSRU): the first 30 years. Rouillon A Int J Tuberc Lung Dis; 1998 Jan; 2(1):5-9. PubMed ID: 9562105 [No Abstract] [Full Text] [Related]
7. NIAID describes research priorities for fighting drug-resistant tuberculosis. Home Healthc Nurse; 2008 Sep; 26(8):448-9. PubMed ID: 18787482 [No Abstract] [Full Text] [Related]
8. [Tuberculosis in Somalia with consequences in Sweden]. Winstrand A; Kulane A; von Schreeb J Lakartidningen; 2010 Dec; 107(51-52):3279-81. PubMed ID: 21294349 [No Abstract] [Full Text] [Related]
9. DOTS and drug resistance: a silver lining to a darkening cloud. Chaisson RE; Coberly JS; De Cock KM Int J Tuberc Lung Dis; 1999 Jan; 3(1):1-3. PubMed ID: 10094162 [No Abstract] [Full Text] [Related]
10. Control of tuberculosis in India. Mohapatra PR Lancet; 2003 Oct; 362(9391):1243. PubMed ID: 14568763 [No Abstract] [Full Text] [Related]
11. Tuberculosis and HIV: renewed challenge. Kritski AL; Lapa e Silva JR; Conde MB Mem Inst Oswaldo Cruz; 1998; 93(3):417-21. PubMed ID: 9698881 [No Abstract] [Full Text] [Related]
12. HIV infection, tuberculosis and non-tuberculous mycobacteria. Churchyard GJ; Grant AD S Afr Med J; 2000 May; 90(5):472-6. PubMed ID: 10901814 [No Abstract] [Full Text] [Related]
13. [Tuberculosis and HIV infection: experience of the national tuberculosis prevention program in Djibouti: 1990-1996]. Renoux E; Matan AB; Sevre JP; Mohamed Ali I; Chami D; Vincent V Med Trop (Mars); 2002; 62(2):171-6. PubMed ID: 12192716 [TBL] [Abstract][Full Text] [Related]
14. The "new tuberculosis" and its changing epidemiology. Nosocomial transmission and hospital discharge standards. Blumberg HM J Med Assoc Ga; 1995 May; 84(5):209-14. PubMed ID: 7782706 [No Abstract] [Full Text] [Related]
15. [Reasons for drug-resistant tuberculosis emergence]. Tu DH Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006 [No Abstract] [Full Text] [Related]
17. The HIV-tuberculosis time bomb: how can hospitals in developing countries cope? Walley J World Hosp Health Serv; 1994; 30(1):16-9. PubMed ID: 10135090 [TBL] [Abstract][Full Text] [Related]
18. Extensively drug-resistant (XDR) tuberculosis: an old and new threat. Fattorini L; Migliori GB; Cassone A Ann Ist Super Sanita; 2007; 43(4):317-9. PubMed ID: 18209265 [TBL] [Abstract][Full Text] [Related]
20. Immune reconstitution syndrome following initiation of antiretroviral therapy in a patient with HIV infection and multidrug-resistant tuberculosis. Swaminathan S; Padmapriyadarsini C; Narendran G; Thomas BE; Anand S; Rajyalakshmi A Indian J Chest Dis Allied Sci; 2005; 47(4):299-304. PubMed ID: 16255403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]